Write in a clean editor, then format for Oncology Issues in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Oncology Issues is a peer-reviewed journal published by Taylor & Francis, covering Economic and Financial Impacts of Cancer, Advances in Oncology and Radiotherapy, Health Systems, Economic Evaluations, Quality of Life.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Oncology Issues 12 (3): 45–58.
Formats any DOI in Oncology Issues style. No sign-up. |
| Publishes research in | Economic and Financial Impacts of Cancer Advances in Oncology and Radiotherapy Health Systems, Economic Evaluations, Quality of Life Palliative Care and End-of-Life Issues Cancer survivorship and care |
| ISSN | 1046-3356 |
| Citation impact (2-yr) | 0.37 |
| h-index | 16 |
| i10-index | 28 |
| Total citations | 3,347 |
| Top institutions publishing here | Twitter (United States) |
| Journal website | www.tandfonline.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
With extensive updated information on everything from treatment of hypertension to hepatitis C, AHFS (R) Drug Information (R) 2017 is a necessary addition to your pharmacy's resources. With content supported by more than 89,000 total references and reviewed by over 500 professionals, it helps you protect your patients and your practice. The only print compendium…
Click to increase image sizeClick to decrease image size Additional informationNotes on contributorsLisa A. GurskiLisa A. Gurski, BS, is a doctoral student in the biological sciences department and the Center for Translational Cancer Research at the University of Delaware in Newark, Del.; Nicholas J. Petrelli, MD, is the medical director for the Helen F. Graham…
Since 1971, when President Richard Nixon declared a “War on Cancer,” profound advances in biomedical science, especially at the molecular/genetic level, have increased longevity and improved quality of life for many patients. Despite our tremendous scientific advances, some populations in this country bear a heavier burden of cancer, particularly the poor and underserved, as evidenced…
